NSPR Latest Quarter’s Earnings
Announce Date8/14/2026
EPS Actual (USD)-0.17
Revenue Actual (USD)1.77M
InspireMD Inc Earnings Dates & Reports
This page offers detailed InspireMD Inc earnings data including the latest InspireMD Inc earnings report, the upcoming InspireMD Inc earnings date, historical data and InspireMD Inc earnings call news.
NSPR Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
NSPR FY2025 Earnings
EPS (YoY)-0.760.64%
Revenue (YoY)8.98M28.11%
InspireMD Inc (NSPR) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/14/2026 | 06/2026 | -0.17/-0.20 | 1.77M/1.38M | 15.41% | 27.96% |
| 5/4/2026 | 03/2026 | -0.16/-0.18 | 3.40M/2.70M | 9.25% | 25.77% |
| 3/18/2026 | 12/2025 | -0.14/-0.19 | 3.15M/2.63M | 26.32% | 19.93% |
| 11/4/2025 | 09/2025 | -0.17/-0.20 | 2.52M/1.76M | 11.29% | 43.35% |
| 8/4/2025 | 06/2025 | -0.26/-0.26 | 1.78M/1.52M | 0.83% | 16.97% |
| 5/8/2025 | 03/2025 | -0.22/-0.20 | 1.53M/1.45M | -11.67% | 5.45% |
| 3/12/2025 | 12/2024 | -0.19/-0.20 | 1.95M/1.82M | 4.91% | 7.29% |
| 11/12/2024 | 09/2024 | -0.16/-0.20 | 1.81M/1.74M | 18.44% | 4.02% |
InspireMD Inc Latest Earnings Call Transcripts
InspireMD (NSPR) Q2 2026 Earnings Call: Recall Impact and FDA Catalysts
InspireMD Q2 2026 revenue was $1.8 million as recall charges pressured margins. International sales rose 21%, with key FDA decisions targeted for Q4.